Vanda Pharmaceuticals Reports Director/Officer Changes
Ticker: VNDA · Form: 8-K · Filed: Feb 20, 2025 · CIK: 1347178
| Field | Detail |
|---|---|
| Company | Vanda Pharmaceuticals Inc. (VNDA) |
| Form Type | 8-K |
| Filed Date | Feb 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes
Related Tickers: VNDA
TL;DR
Vanda Pharma (VNDA) filed an 8-K on Feb 20th detailing director/officer changes effective Feb 18th.
AI Summary
Vanda Pharmaceuticals Inc. filed an 8-K on February 20, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. The filing covers events that occurred on February 18, 2025.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus.
Risk Assessment
Risk Level: low — This filing is routine corporate governance disclosure and does not inherently present new financial or operational risks.
Key Players & Entities
- Vanda Pharmaceuticals Inc. (company) — Registrant
- February 20, 2025 (date) — Filing Date
- February 18, 2025 (date) — Earliest Event Date
FAQ
What specific items are being reported in this 8-K filing?
This 8-K filing reports on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements of certain officers.
What is the exact date of the earliest event reported in the filing?
The date of the earliest event reported is February 18, 2025.
What is the filing date of this 8-K report?
The 8-K report was filed on February 20, 2025.
What is the principal executive office address for Vanda Pharmaceuticals Inc.?
The address of the principal executive offices is 2200 Pennsylvania Avenue NW, Suite 300E, Washington, DC 20037.
What is Vanda Pharmaceuticals Inc.'s state of incorporation and IRS Employer Identification Number?
Vanda Pharmaceuticals Inc. is incorporated in Delaware and its IRS Employer Identification Number is 03-0491827.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 20, 2025 regarding Vanda Pharmaceuticals Inc. (VNDA).